// AST – IMS - [DMinute_ROS]

Steinberg Global Asset Management Upped By $1.29 Million Its Neurocrine Biosciences (NBIX) Stake; Stericycle, Inc. (SRCL) Had 0 Bullish Analysts

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Logo

Among 3 analysts covering Stericycle (NASDAQ:SRCL), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. Stericycle had 6 analyst reports since August 6, 2018 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Wednesday, December 19 with “Neutral”. The stock has “Underperform” rating by Bank of America on Friday, November 2. BMO Capital Markets maintained it with “Market Perform” rating and $63 target in Monday, August 6 report. On Friday, November 2 the stock rating was maintained by Robert W. Baird with “Neutral”. The firm has “Market Perform” rating by BMO Capital Markets given on Tuesday, November 6. See Stericycle, Inc. (NASDAQ:SRCL) latest ratings:

19/12/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $56 New Target: $44 Maintain
06/11/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $58 New Target: $51 Maintain
02/11/2018 Broker: Bank of America Old Rating: Underperform New Rating: Underperform Old Target: $53 New Target: $50 Maintain
02/11/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $70 New Target: $56 Maintain
23/10/2018 Broker: Bank of America Rating: Underperform New Target: $53 Initiates Coverage On
06/08/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $71 New Target: $63 Maintain

Steinberg Global Asset Management increased Neurocrine Biosciences Inc (NBIX) stake by 84.51% reported in 2018Q3 SEC filing. Steinberg Global Asset Management acquired 10,538 shares as Neurocrine Biosciences Inc (NBIX)’s stock declined 27.61%. The Steinberg Global Asset Management holds 23,008 shares with $2.83 million value, up from 12,470 last quarter. Neurocrine Biosciences Inc now has $7.70 billion valuation. The stock decreased 2.23% or $1.94 during the last trading session, reaching $84.89. About 541,501 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 18.36% since January 14, 2018 and is uptrending. It has outperformed by 18.36% the S&P500. Some Historical NBIX News: 30/04/2018 – Neurocrine 1Q Rev $71.1M; 25/04/2018 – NEUROCRINE SAYS INGREZZA IMPROVES TARDIVE DYSKINESIA SYMPTOMS; 27/04/2018 – AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) An; 08/05/2018 – NEUROCRINE PRESENTS NEW QUALITY OF LIFE DATA FROM RE-KINECT; 08/05/2018 – Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tar; 30/04/2018 – Neurocrine 1Q Loss/Shr 47c; 25/04/2018 – Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions; 18/04/2018 – Neurocrine Biosciences to Present New Data from INGREZZA® at the 2018 American Academy of Neurology Annual Meeting; 30/04/2018 – Neurocrine Sees 2018 Operating Expense $395M-$420M; 30/04/2018 – NEUROCRINE BIO 1Q LOSS/SHR 47C, EST. LOSS/SHR 30C

Steinberg Global Asset Management decreased Jp Morgan Exchange Traded Fd stake by 264,092 shares to 29,014 valued at $1.46 million in 2018Q3. It also reduced Duke Energy Corp New (NYSE:DUK) stake by 3,776 shares and now owns 60,450 shares. Ishares Tr (IVW) was reduced too.

Investors sentiment increased to 1.33 in Q3 2018. Its up 0.12, from 1.21 in 2018Q2. It increased, as 15 investors sold NBIX shares while 95 reduced holdings. 75 funds opened positions while 71 raised stakes. 86.00 million shares or 5.83% less from 91.33 million shares in 2018Q2 were reported. California-based Capital Invsts has invested 0.01% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Hanseatic Management Services Inc invested in 1.2% or 10,507 shares. Goldman Sachs Grp Inc holds 0.04% or 1.31M shares. Moreover, Artisan Partners Limited Partnership has 0.43% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Pub Employees Retirement Association Of Colorado has invested 0.13% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 944,624 are owned by Baker Bros Advsrs L P. Mutual Of America Cap Mgmt Ltd Liability invested 0.12% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 395 were accumulated by Next Gru. The New York-based Timessquare Capital Mgmt Ltd Llc has invested 0.78% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Castleark Mgmt Limited Liability Corp holds 0.16% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 46,665 shares. Sigma Planning owns 0.02% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 2,370 shares. Moreover, Dubuque Bancorp And Trust has 0.04% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 2,225 shares. Alpha Cubed Invs owns 0.47% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 36,000 shares. Bollard Group holds 0% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 200 shares. Toronto Dominion State Bank holds 5 shares or 0% of its portfolio.

Among 8 analysts covering Neurocrine Biosciences (NASDAQ:NBIX), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Neurocrine Biosciences had 10 analyst reports since July 25, 2018 according to SRatingsIntel. Barclays Capital maintained the stock with “Overweight” rating in Wednesday, August 1 report. The firm has “Overweight” rating given on Tuesday, November 6 by Morgan Stanley. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, September 20. Robert W. Baird maintained the shares of NBIX in report on Wednesday, July 25 with “Outperform” rating.

Since October 29, 2018, it had 0 insider purchases, and 9 selling transactions for $12.63 million activity. ABERNETHY MATT sold 1,178 shares worth $106,020. $3.99 million worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Bozigian Haig P. on Thursday, November 8. Lloyd-Smith Malcolm sold $990,096 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Tuesday, November 6. On Tuesday, January 8 the insider ROBERTS EIRY sold $156,159. POPS RICHARD F had sold 5,500 shares worth $589,237. $1.72M worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by LYONS GARY A.

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. The company has market cap of $3.55 billion. The firm collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services. It has a 22.79 P/E ratio. The Company’s services and products include medical waste management, reusable sharps disposal management, pharmaceutical waste, and hazardous waste management services; integrated waste stream solutions program; sustainability and recycling services for expired or unused inventory; secure information destruction and hard drive destruction services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products.

Investors sentiment decreased to 0.99 in Q3 2018. Its down 0.01, from 1 in 2018Q2. It fall, as 43 investors sold Stericycle, Inc. shares while 135 reduced holdings. 52 funds opened positions while 124 raised stakes. 83.95 million shares or 7.22% more from 78.30 million shares in 2018Q2 were reported. Rmb Capital Mgmt Limited Liability Corp holds 0.01% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL) for 4,040 shares. Tarbox Family Office Incorporated has invested 0% in Stericycle, Inc. (NASDAQ:SRCL). Sei Investments has 0.02% invested in Stericycle, Inc. (NASDAQ:SRCL). 111,435 are owned by State Board Of Administration Of Florida Retirement Systems. Moreover, Leuthold Gp Lc has 0.47% invested in Stericycle, Inc. (NASDAQ:SRCL). Nuveen Asset Mgmt Limited Liability Corporation, a Illinois-based fund reported 56,015 shares. Of Vermont holds 0% or 285 shares. Strs Ohio invested 0.12% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Dimensional Fund Advsrs L P invested 0.02% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Ubs Asset Mngmt Americas holds 0% in Stericycle, Inc. (NASDAQ:SRCL) or 3.31M shares. Barnett Commerce Inc holds 0.05% or 1,755 shares. Ironwood Financial Llc holds 250 shares. State Of Wisconsin Board reported 0.01% stake. American Grp owns 31,047 shares. Elk Creek Prtnrs Llc accumulated 66,671 shares.

Since July 27, 2018, it had 0 buys, and 1 insider sale for $353,750 activity. Ginnetti Daniel had sold 5,000 shares worth $353,750.

The stock decreased 0.87% or $0.34 during the last trading session, reaching $39.2. About 97,513 shares traded. Stericycle, Inc. (NASDAQ:SRCL) has declined 36.80% since January 14, 2018 and is downtrending. It has underperformed by 36.80% the S&P500. Some Historical SRCL News: 03/05/2018 – STERICYCLE INC SEES FULL-YEAR 2018 REVENUES $3,500 MLN – $3,640 MLN; 03/05/2018 – STERICYCLE INC SEES FULL-YEAR 2018 NET CASH FROM OPERATING ACTIVITIES $510 MLN; 21/03/2018 Stericycle, Inc. Announces Changes to Board of Directors; 11/04/2018 – Stericycle, Inc. Partners with National Safety Council to Bring Opioid Crisis Campaign to the White House; 03/05/2018 – Stericycle Sees FY Adj EPS $4.45-Adj EPS $4.85; 27/04/2018 – TEAMSTERS URGES STERICYCLE INC’S SHAREHOLDERS VOTE AGAINST RE-ELECTION OF DIRECTORS JOHN PATIENCE AND MARK MILLER – SEC FILING; 03/05/2018 – STERICYCLE 1Q ADJ EPS $1.21, EST. $1.05; 03/05/2018 – STERICYCLE INC SRCL.O FY2018 SHR VIEW $4.55, REV VIEW $3.56 BLN — THOMSON REUTERS l/B/E/S; 23/03/2018 – S&PGR Downgrades Stericycle Inc. To ‘BBB+’ From ‘A-‘, Otlk Neg; 30/05/2018 – Stericycle Access Event Set By Northcoast Research for Jun. 6

Stericycle, Inc. (NASDAQ:SRCL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.